We are live on ! Find out more
PAS

Park Avenue Securities Portfolio holdings

AUM $16B
1-Year Est. Return 26.77%
This Fund
S&P 500
This Quarter Est. Return
+5.86%
1 Year Est. Return
+26.77%
3 Year Est. Return
+71.01%
5 Year Est. Return
+71.45%
10 Year Est. Return
+187.53%
AUM
$8.9B
AUM Growth
+$718M
Cap. Flow
+$271M
Cap. Flow %
3.05%
Top 10 Hldgs %
40.13%
Holding
1,464
New
109
Increased
410
Reduced
845
Closed
85

Sector Composition

Rank Sector Weight
1 Technology 6.27%
2 Financials 3.26%
3 Healthcare 2.71%
4 Industrials 2.15%
5 Consumer Discretionary 2.14%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
THG icon
851
Hanover Insurance
THG
$8.1B
$676K 0.01%
4,563
-308
-6% -$42.3K
BJ icon
852
BJs Wholesale Club
BJ
$12.5B
$674K 0.01%
8,170
-2,126
-21% -$180K
ONON icon
853
On Holding
ONON
$12.1B
$674K 0.01%
13,441
+2,194
+20% +$94.1K
SYY icon
854
Sysco
SYY
$40.8B
$674K 0.01%
8,640
-2,890
-25% -$217K
ALGN icon
855
Align Technology
ALGN
$12.1B
$671K 0.01%
2,640
+88
+3% +$20.8K
BALL icon
856
Ball Corp
BALL
$17.3B
$670K 0.01%
9,872
+5,819
+144% +$369K
DOW icon
857
Dow Inc
DOW
$21.9B
$670K 0.01%
12,256
-2,319
-16% -$122K
BCS icon
858
Barclays
BCS
$92.7B
$668K 0.01%
54,981
-16,034
-23% -$188K
HALO icon
859
Halozyme
HALO
$9.79B
$666K 0.01%
11,638
+2,343
+25% +$134K
BLV icon
860
Vanguard Long-Term Bond ETF
BLV
$5.71B
$665K 0.01%
8,848
-370
-4% -$27.2K
GRMN
861
Garmin
GRMN
$56.7B
$664K 0.01%
3,771
-72
-2% -$12.4K
NBIX icon
862
Neurocrine Biosciences
NBIX
$16.8B
$662K 0.01%
5,744
-4,189
-42% -$574K
BDX icon
863
Becton Dickinson
BDX
$45.6B
$659K 0.01%
2,735
+584
+27% +$137K
CRL icon
864
Charles River Laboratories
CRL
$11.2B
$659K 0.01%
3,344
-557
-14% -$116K
LOPE icon
865
Grand Canyon Education
LOPE
$3.79B
$658K 0.01%
4,636
-797
-15% -$115K
WRB icon
866
W.R. Berkley
WRB
$26.9B
$658K 0.01%
11,606
-727
-6% -$40.8K
GDX icon
867
VanEck Gold Miners ETF
GDX
$22.7B
$657K 0.01%
16,510
+1,294
+9% +$49K
ARGX icon
868
argenx
ARGX
$53.4B
$656K 0.01%
1,211
-113
-9% -$57.1K
DFUV icon
869
Dimensional US Marketwide Value ETF
DFUV
$15.4B
$656K 0.01%
15,731
DGX icon
870
Quest Diagnostics
DGX
$25.7B
$654K 0.01%
4,214
+1,049
+33% +$157K
MINT icon
871
PIMCO Enhanced Short Maturity Active Exchange-Traded Fund
MINT
$16.9B
$654K 0.01%
6,492
-5,566
-46% -$559K
REM icon
872
iShares Mortgage Real Estate ETF
REM
$539M
$652K 0.01%
27,464
+297
+1% +$6.97K
IBP icon
873
Installed Building Products
IBP
$6.01B
$649K 0.01%
2,635
+505
+24% +$114K
CDW icon
874
CDW
CDW
$18.9B
$648K 0.01%
2,865
-424
-13% -$94.1K
HXL icon
875
Hexcel
HXL
$7.79B
$648K 0.01%
10,485
-2,701
-20% -$170K

Similar funds

Park Avenue Securities's Q3 2024 Portfolio in Review

As of Q3 2024, Park Avenue Securities held 1,464 positions worth $8.9B, up 8.8% from $8.18B the previous quarter. Its ten largest holdings account for 40% of the portfolio.

Park Avenue Securities deployed $271M of net new capital in Q3 2024, opening 109 new positions and adding to 410 existing holdings. Its largest new stake was BlackRock US Equity Factor Rotation ETF: 6,370,527 shares worth $315M.

By sector, the portfolio is most concentrated in Technology at 6.3% of assets, down from 7.2% a quarter earlier, followed by Financials and Healthcare.

On the sell side, the largest reduction was iShares Core S&P 500 ETF, an estimated $113M trimmed.

  • Park Avenue Securities's largest Q3 2024 buy was BlackRock US Equity Factor Rotation ETF: 6,370,527 shares worth $315M.
  • Park Avenue Securities added most to iShares MSCI EAFE Value ETF in Q3 2024, an estimated $159M increase.
  • Park Avenue Securities's biggest Q3 2024 reduction was iShares Core S&P 500 ETF, cutting an estimated $113M.
  • Park Avenue Securities fully exited Invesco S&P 500 GARP ETF in Q3 2024, selling an estimated $11.8M.
  • Park Avenue Securities's ten largest holdings make up 40% of its $8.9B portfolio in Q3 2024.
  • Park Avenue Securities opened 109 new positions and closed 85 in Q3 2024.
  • Park Avenue Securities's portfolio value rose 8.8% quarter-over-quarter to $8.9B.

Based on Park Avenue Securities's 13F filing for Q3 2024, filed 3 Oct 2024.